Early lenalidomide delays progression of smoldering multiple myelomaJuly 31, 2013Lymphoma & Plasma Cell Disorders
Pomalidomide plus low-dose dexamethasone may be new standard for MMJuly 10, 2013Lymphoma & Plasma Cell Disorders
Rituximab plus chlorambucil extend event-free survival in MALT lymphomaJuly 3, 2013Lymphoma & Plasma Cell Disorders
Idelalisib and rituximab produce responses in 97% with CLLJune 11, 2013Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Utility of routine CT scans questioned in B-cell lymphoma surveillanceMay 16, 2013Lymphoma & Plasma Cell Disorders
Rituximab may obviate radiation in mediastinal B-cell lymphomaApril 10, 2013Lymphoma & Plasma Cell Disorders
Alpha-fetoprotein useful marker in HCCMarch 7, 2013GastroenterologyLymphoma & Plasma Cell DisordersGastrointestinal Cancer
FDA approves pomalidomide for advanced multiple myelomaFebruary 8, 2013Lymphoma & Plasma Cell Disorders
FDA approves generic doxorubicin to address shortage February 4, 2013Lymphoma & Plasma Cell DisordersGynecologic Cancer
PET projects treatment response in adult Hodgkin's diseaseJanuary 30, 2013Lymphoma & Plasma Cell DisordersRare Diseases
Transplants don't boost overall survival in high-risk DLBCLJanuary 25, 2013Lymphoma & Plasma Cell Disorders
